Skip to main navigation

Histogenics

  • About Us
    • History
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Products & Platforms
    • NeoCart
    • Platform
    • About Restorative Cell Therapies
    • About Cartilage Repair
  • Partnering
    • Brigham and Women’s Hospital
    • Cornell University
    • MEDINET
  • Investors
    • Stock Information
    • SEC Filings
    • Calendar of Events
    • Presentations & Publications
    • Corporate Governance
    • Investors FAQs
  • News
    • Press Releases
  • Contact
    • Subscribe
  • Careers
Home/ Investors/ 3

Investors

Investor Relations

  • Investor Overview
  • Stock Information
  • SEC Filings
  • Calendar of Events
  • Presentations & Publications
  • Corporate Governance
  • Investor FAQs

SEC Filing Details

Document Details

Form
3
Filing Date
Jul 22, 2019
Document Date
Jul 19, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Histogenics Corp
Issuer
Ocugen, Inc.
Filer
Hood David C.

Filing Formats

View HTML
Download PDF
Download DOC

Shareholder Tools

  • Print Page
  • RSS Feeds
  • E-mail Alerts
  • IR Contacts

830 Winter Street, 3rd Floor

Waltham, MA 02451

tel 781.547.7900

fax 781.547.4452

Email: InvestorRelations@histogenics.com

Accounts Payable Email: accountspayable@histogenics.com

About Us

  • History
  • Management
  • Board of Directors
  • Scientific Advisory Board

Products & Platform

  • Products & Platforms
  • NeoCart
  • Platform
  • About Restorative Cell Therapies
  • About Cartilage Repair

Investors

  • Investor Overview
  • Stock Information
  • SEC Filings
  • Calendar of Events
  • Presentations & Publications
  • Corporate Governance
  • Investor FAQs

News

  • Press Releases

Contact

  • Contact
  • Subscribe
  • Careers

Copyright © 2018 · Histogenics
Terms & Conditions | Forward Looking Statements